Skip to content
Screener

Verrica Pharmaceuticals Inc. VRCA Q4 2025 Annual earnings

Reported March 11, 2026 · Before market open

Revenue$5.1MBeat by $572.0K
EPS-$0.56Miss by $0.13
Revenue estimate$4.5M
EPS estimate-$0.43

Next report

Nov 13, 2026 (in 2 months)
Revenue estimate$6.4M
EPS estimate-$0.58

FAQ

When did Verrica Pharmaceuticals Inc. report Q4 2025 earnings?
Verrica Pharmaceuticals Inc. (VRCA) reported Q4 2025 earnings on March 11, 2026 before market open.
What were Verrica Pharmaceuticals Inc.'s Q4 2025 revenue and EPS?
Verrica Pharmaceuticals Inc. reported revenue of $5.1M and eps of $-0.56 for Q4 2025.
Did Verrica Pharmaceuticals Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $4.5M by $572.0K. EPS missed the consensus estimate of $-0.43 by $0.13.
How did Verrica Pharmaceuticals Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1380.2% from $344.0K a year earlier and eps declined 133.3% from $-0.24.
Where can I find Verrica Pharmaceuticals Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-101126) and the 10-K periodic report (0001660334-26-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.